title: Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage.
abstract: How Fanconi anemia (FA) protein D2 (FANCD2) performs DNA damage repair remains largely elusive. We report here that translesion synthesis DNA polymerase (pol) eta is a novel mediator of FANCD2 function. We found that wild type (wt) FANCD2, not K561R (mt) FANCD2, can interact with pol eta. Upon DNA damage, the interaction of pol eta with FANCD2 occurs earlier than that with PCNA, which is in concert with our finding that FANCD2 monoubiquitination peaks at an earlier time point than that of PCNA monoubiquitination. FANCD2-null FA patient cells (PD20) carrying histone H2B-fused pol eta and wtFANCD2, respectively, show a similar tendency of low Mitomycin C (MMC) sensitivity, while cells transfected with empty vector control or pol eta alone demonstrate a similar high level of MMC sensitivity. It therefore appears that FANCD2 monoubiquitination plays a similar anchor role as histone to bind DNA in regulating pol eta. Collectively, our study indicates that, in the early phase of DNA damage response, FANCD2 plays crucial roles in recruiting pol eta to the sites of DNA damage for repair.
authors: University of Hawaii Cancer Center (UHCC), University of Hawaii, Honolulu, HI, USA.
authors: Dechen
authors: D
authors: Fu
authors: Fred Duafalia
authors: FD
authors: Dudimah
authors: Jun
authors: J
authors: Zhang
authors: Anna
authors: A
authors: Pickering
authors: Jayabal
authors: J
authors: Paneerselvam
authors: Manikandan
authors: M
authors: Palrasu
authors: Hong
authors: H
authors: Wang
authors: Peiwen
authors: P
authors: Fei
mesh_terms: D002460:Cell Line; D002843:Chromatin / Q000378:metabolism; D004249:DNA Damage; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism*; D052236:Fanconi Anemia Complementation Group D2 Protein / Q000737:chemistry / Q000378:metabolism*; D006367:HeLa Cells; D006657:Histones / Q000378:metabolism; D006801:Humans; D016685:Mitomycin / Q000494:pharmacology; D008954:Models, Biological; D046912:Multiprotein Complexes / Q000378:metabolism; D009154:Mutation / Q000235:genetics; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects / Q000528:radiation effects; D017434:Protein Structure, Tertiary; D057149:Ubiquitinated Proteins / Q000378:metabolism; D054875:Ubiquitination / Q000187:drug effects / Q000528:radiation effects; D014466:Ultraviolet Rays; D000099270:Y-Family DNA Polymerases
chemical_list: D002843:Chromatin; D004259:DNA-Directed DNA Polymerase; D052236:Fanconi Anemia Complementation Group D2 Protein; D006657:Histones; D016685:Mitomycin; D046912:Multiprotein Complexes; D018809:Proliferating Cell Nuclear Antigen; D057149:Ubiquitinated Proteins; C499905:FANCD2 protein, human; C112338:Rad30 protein; D000099270:Y-Family DNA Polymerases
keywords: DNA polymerase eta; FANCD2; PCNA; XP-V; cancer susceptibility syndrome; early DNA damage response; error-free TL; genome stability; the FA tumor suppressor pathway; translesion synthesis
references: Cell Cycle. 2004 Aug;3(8):1011-3
references: 15280666
references: Biochem J. 2000 Jul 1;349(Pt 1):1-12
references: 10861204
references: Curr Opin Hematol. 2003 Jan;10(1):68-76
references: 12483114
references: Blood. 2003 Mar 1;101(5):2072
references: 12584146
references: Science. 1996 Dec 6;274(5293):1664-72
references: 8939848
references: Dev Cell. 2007 May;12(5):661-2
references: 17488615
references: Blood. 1988 Jul;72(1):366-7
references: 3291985
references: Mol Cell Biol. 1999 Mar;19(3):2206-11
references: 10022907
references: Nature. 2000 Nov 16;408(6810):307-10
references: 11099028
references: Microbiol Mol Biol Rev. 2009 Mar;73(1):134-54
references: 19258535
references: Cell Cycle. 2012 Mar 15;11(6):1049-50
references: 22391210
references: Mol Cell. 2005 Dec 9;20(5):793-9
references: 16337602
references: Cell Cycle. 2012 Feb 15;11(4):715-20
references: 22374670
references: Mutat Res. 2009 Jul 31;668(1-2):11-9
references: 19061902
references: Nat Rev Genet. 2007 Oct;8(10):735-48
references: 17768402
references: Cell Cycle. 2012 Aug 1;11(15):2947-55
references: 22828653
references: Blood. 1987 Jun;69(6):1637-41
references: 3107630
references: Cell Cycle. 2008 Feb 1;7(3):407-13
references: 18277096
references: Cell Cycle. 2012 Jul 15;11(14):2620-3
references: 22732495
references: Mol Cell. 2005 May 27;18(5):499-505
references: 15916957
references: Nat Genet. 2003 Oct;35(2):165-70
references: 12973351
references: Cell Cycle. 2012 Jun 1;11(11):2128-36
references: 22592530
references: Cell Cycle. 2012 Feb 15;11(4):668-74
references: 22373527
references: Cell Cycle. 2012 Oct 15;11(20):3739-44
references: 22895051
references: Mol Cell Biol. 1991 Apr;11(4):1927-34
references: 2005888
references: Mol Cell. 2005 Dec 9;20(5):783-92
references: 16337601
references: Nucleic Acids Res. 2004 Mar 12;32(5):1738-45
references: 15020710
references: Mol Cell. 2005 Sep 16;19(6):841-7
references: 16168378
references: PLoS One. 2010 Oct 13;5(10):e13313
references: 20967207
references: J Clin Invest. 2010 May;120(5):1524-34
references: 20407210
references: Genes Dev. 2012 Jul 1;26(13):1393-408
references: 22751496
references: Cell Cycle. 2012 Nov 15;11(22):4103-4
references: 23075493
references: Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):128-42
references: 15668941
references: Nature. 1975 Oct 9;257(5526):501-3
references: 1178054
references: Mol Cell. 2004 May 21;14(4):491-500
references: 15149598
references: Adv Genet. 2001;43:71-102
references: 11037299
references: Am J Hematol. 1996 Oct;53(2):99-110
references: 8892734
references: Mol Cell. 2004 Aug 27;15(4):607-20
references: 15327776
references: Mutat Res. 2009 Jul 31;668(1-2):27-41
references: 19101576
references: Science. 2005 Dec 16;310(5755):1821-4
references: 16357261
references: Cell Cycle. 2012 Aug 15;11(16):2997-3002
references: 22825251
references: Nature. 1968 May 18;218(5142):652-6
references: 5655953